S
KNSA icon

SignatureFD’s Kiniksa Pharmaceuticals KNSA Stock Holding History

SignatureFD’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.2K Buy
1,113
+23
+2% +$1.19K ﹤0.01% 1660
2026
Q1 		$52.5K Buy
1,090
+143
+15% +$6.33K ﹤0.01% 1689
2025
Q4 		$39.1K Hold
947
– – ﹤0.01% 1790
2025
Q3 		$36.8K Hold
947
– – ﹤0.01% 1812
2025
Q2 		$26.2K Sell
947
-40
-4% -$1.02K ﹤0.01% 1922
2025
Q1 		$21.9K Buy
987
+44
+5% +$906 ﹤0.01% 2015
2024
Q4 		$18.7K Hold
943
– – ﹤0.01% 2092
2024
Q3 		$23.6K Hold
943
– – ﹤0.01% 1963
2024
Q2 		$17.6K Hold
943
– – ﹤0.01% 2028
2024
Q1 		$18.6K Hold
943
– – ﹤0.01% 2032
2023
Q4 		$16.5K Sell
943
-31
-3% -$510 ﹤0.01% 2017
2023
Q3 		$16.9K Hold
974
– – ﹤0.01% 1935
2023
Q2 		$13.7K Buy
974
+865
+794% +$11.6K ﹤0.01% 2088
2023
Q1 		$1.17K Sell
109
-57
-34% -$751 ﹤0.01% 2948
2022
Q4 		$2.49K Sell
166
-270
-62% -$3.93K ﹤0.01% 2734
2022
Q3 		$6K Buy
436
+336
+336% +$3.83K ﹤0.01% 2357
2022
Q2 		$1K Buy
100
+43
+75% +$401 ﹤0.01% 2941
2022
Q1 		$1K Buy
+57
New +$604 ﹤0.01% 3014
2021
Q4 		– Sell
-66
Closed -$1K – 3188
2021
Q3 		$1K Buy
+66
New +$860 ﹤0.01% 2847

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

SignatureFD's KNSA Position: Q2 2026 in Review

SignatureFD increased its Kiniksa Pharmaceuticals (KNSA) stake by 2.1% in Q2 2026, buying an estimated $1.19K and bringing the position to 1,113 shares worth $71.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1660.

SignatureFD first reported a position in KNSA in Q3 2021 and has held it in 19 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • SignatureFD held 1,113 shares of Kiniksa Pharmaceuticals worth $71.2K as of Q2 2026.
  • SignatureFD bought 23 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $1.19K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1660 holding.
  • SignatureFD first reported a position in Kiniksa Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.